The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Department of Ultrasound, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.
BMC Neurol. 2024 Feb 20;24(1):71. doi: 10.1186/s12883-024-03557-8.
Little is known regarding the leading risk factors for dementia/Alzheimer's disease (AD) in individuals with and without APOE4. The identification of key risk factors for dementia/Alzheimer's disease (AD) in individuals with and without the APOE4 gene is of significant importance in global health.
Our analysis included 110,354 APOE4 carriers and 220,708 age- and sex-matched controls aged 40-73 years at baseline (between 2006-2010) from UK Biobank. Incident dementia was ascertained using hospital inpatient, or death records until January 2021. Individuals of non-European ancestry were excluded. Furthermore, individuals without medical record linkage were excluded from the analysis. Moderation analysis was tested for 134 individual factors.
During a median follow-up of 11.9 years, 4,764 cases of incident all-cause dementia and 2065 incident AD cases were documented. Hazard ratios (95% CIs) for all-cause dementia and AD associated with APOE4 were 2.70(2.55-2.85) and 3.72(3.40-4.07), respectively. In APOE4 carriers, the leading risk factors for all-cause dementia included low self-rated overall health, low household income, high multimorbidity risk score, long-term illness, high neutrophil percentage, and high nitrogen dioxide air pollution. In non-APOE4 carriers, the leading risk factors included high multimorbidity risk score, low overall self-rated health, low household income, long-term illness, high microalbumin in urine, high neutrophil count, and low greenspace percentage. Population attributable risk for these individual risk factors combined was 65.1%, and 85.8% in APOE4 and non-APOE4 carriers, respectively. For 20 risk factors including multimorbidity risk score, unhealthy lifestyle habits, and particulate matter air pollutants, their associations with incident dementia were stronger in non-APOE4 carriers. For only 2 risk factors (mother's history of dementia, low C-reactive protein), their associations with incident all-cause dementia were stronger in APOE4 carriers.
Our findings provide evidence for personalized preventative approaches to dementia/AD in APOE4 and non-APOE4 carriers. A mother's history of dementia and low levels of C-reactive protein were more important risk factors of dementia in APOE4 carriers whereas leading risk factors including unhealthy lifestyle habits, multimorbidity risk score, inflammation and immune-related markers were more predictive of dementia in non-APOE4 carriers.
对于携带 APOE4 和不携带 APOE4 的个体,导致痴呆/阿尔茨海默病(AD)的主要风险因素知之甚少。确定携带和不携带 APOE4 基因的个体患痴呆/阿尔茨海默病(AD)的关键风险因素对于全球健康具有重要意义。
我们的分析包括英国生物银行 110354 名 APOE4 携带者和 220708 名年龄和性别匹配的对照者,基线年龄为 40-73 岁(2006-2010 年之间)。通过医院住院或死亡记录确定痴呆症的发病情况,直至 2021 年 1 月。排除非欧洲血统的个体。此外,未进行医疗记录链接的个体也被排除在分析之外。对 134 个个体因素进行了调节分析。
在中位随访 11.9 年期间,记录了 4764 例全因痴呆症和 2065 例 AD 病例。与 APOE4 相关的全因痴呆症和 AD 的风险比(95%CI)分别为 2.70(2.55-2.85)和 3.72(3.40-4.07)。在 APOE4 携带者中,全因痴呆症的主要风险因素包括自我评估总体健康状况较差、家庭收入较低、高多重疾病风险评分、长期患病、中性粒细胞百分比高和二氧化氮空气污染。在非 APOE4 携带者中,全因痴呆症的主要风险因素包括高多重疾病风险评分、总体自我评估健康状况较差、家庭收入较低、长期患病、尿中微量白蛋白高、中性粒细胞计数高和绿地百分比低。这些个体风险因素的人群归因风险分别为 65.1%和 APOE4 和非 APOE4 携带者的 85.8%。对于包括多重疾病风险评分、不健康的生活方式习惯和颗粒物空气污染物在内的 20 个风险因素,它们与非 APOE4 携带者的痴呆症发病之间的关联更强。对于仅有的 2 个风险因素(母亲的痴呆症病史、低 C 反应蛋白),它们与全因痴呆症的发病关联在 APOE4 携带者中更强。
我们的研究结果为 APOE4 和非 APOE4 携带者的痴呆症/AD 提供了个性化预防方法的证据。母亲的痴呆症病史和低 C 反应蛋白水平是 APOE4 携带者发生痴呆症的更重要的风险因素,而包括不健康的生活方式习惯、多重疾病风险评分、炎症和免疫相关标志物在内的主要风险因素在非 APOE4 携带者中更能预测痴呆症。